The draft genome and transcriptome of Cannabis sativa.
van Bakel H, Stout JM, Cote AG, Tallon CM, Sharpe AG, Hughes TR, Page JE. · 2011
Read The draft genome and transcriptome of Cannabis sativa. by van Bakel H, Stout JM, Cote AG, Tallon CM, Sharpe AG, Hughes TR, Page JE. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3359589.txt.
Introduction
Van Bakel and co-workers produced the first draft genome and transcriptome of Cannabis sativa, a plant cultivated for fibre, food, medicine, and its intoxicating effect. They sequenced the high-potency marijuana strain Purple Kush and compared its gene activity with that of the hemp cultivar Finola, bred for fibre and seed.
The draft genome spans 534 megabases and contains some thirty thousand genes. Genes for cannabinoid production were expressed more strongly in Purple Kush. Crucially, the enzyme making the psychoactive compound's precursor appeared only in Purple Kush. Finola instead carried the enzyme for a non-psychoactive counterpart. That swap neatly explains the chemical split between marijuana and hemp.
Catalog record
| CREATOR | van Bakel H, Stout JM, Cote AG, Tallon CM, Sharpe AG, Hughes TR, Page JE. |
|---|---|
| YEAR | 2011 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The draft genome and transcriptome of Cannabis sativa By Harm van Bakel, Jake M Stout, Atina G Cote, Carling M Tallon, Andrew G Sharpe, Timothy R Hughes, Jonathan E Page Published in: Genome Biology DOI: 10.1186/gb-2011-12-10-r102 ABSTRACT Abstract Background Cannabis sativa has been cultivated throughout human history as a source of fiber, oil and food, and for its medicinal and intoxicating properties. Selective breeding has produced cannabis plants for specific uses, including high-potency marijuana strains and hemp cultivars for fiber and seed production. The molecular biology underlying cannabinoid biosynthesis and other traits of interest is largely unexplored. Results We sequenced genomic DNA and RNA from the marijuana strain Purple Kush using shortread approaches. We report a draft haploid genome sequence of 534 Mb and a transcriptome of 30,000 genes. Comparison of the transcriptome of Purple Kush with that of the hemp cultivar 'Finola' revealed that many genes encoding proteins involved in cannabinoid and precursor pathways are more highly expressed in Purple Kush than in 'Finola'. The exclusive occurrence of Δ9-tetrahydrocannabinolic acid synthase in the Purple Kush transcriptome, and its replacement by cannabidiolic acid synthase in 'Finola', may explain why the psychoactive cannabinoid Δ9-tetrahydrocannabinol (THC) is produced in marijuana but not in hemp. Resequencing the hemp cultivars 'Finola' and 'USO-31' showed little difference in gene copy numbers of cannabinoid pathway enzymes. However, single nucleotide variant analysis uncovered a relatively high level of variation among four cannabis types, and supported a separation of marijuana and hemp. Conclusions The availability of the Cannabis sativa genome enables the study of a multifunctional plant that occupies a unique role in human culture. Its availability will aid the development of therapeutic marijuana strains with tailored cannabinoid profiles and provide a basis for the breeding of hemp with improved agronomic characteristics. Keywords: Cannabaceae, cannabis, marijuana, hemp, genome, transcriptome, cannabinoid BACKGROUND One of the earliest domesticated plant species, Cannabis sativa L. (marijuana, hemp; Cannabaceae) has been used for millennia as a source of fibre, oil- and protein-rich achenes ("seeds") and for its medicinal and psychoactive properties. From its site of domestication in Central Asia, the cultivation of cannabis spread in ancient times throughout Asia and Europe and is now one of the most widely distributed cultivated plants [1]. Hemp fibre was used for textile production in China more than 6000 years BP (before present) [2]. Archaeological evidence for the medicinal or shamanistic use of cannabis has been found in a 2700-year old tomb in north-western China and a Judean tomb from 1700 years BP [3,4]. Currently cannabis and its derivatives such as hashish are the most widely consumed illicit drugs in the world [5]. Its use is also increasingly recognized in the treatment of a range of diseases such as multiple sclerosis and conditions with chronic pain [6,7]. In addition, hemp forms of cannabis are grown as an agricultural crop in many countries. Cannabis is an erect annual herb with a dioecious breeding system, although monoecious plants exist. Wild and cultivated forms of cannabis are morphologically variable, resulting in confusion and controversy over the taxonomic organization of the genus (see [8] for review). Some authors have proposed a monotypic genus, C. sativa, while others have argued that Cannabis is composed of two species, Cannabis sativa and Cannabis indica, and some have included a third species, Cannabis ruderalis, in the genus. In light of the taxonomic uncertainty, we use C. sativa to describe the plants analyzed in this study. The unique pharmacological properties of cannabis are due to the presence of cannabinoids, a group of more than 100 natural products that mainly accumulate in female flowers ("buds") [9,10]. Δ9-Tetrahydrocannabinol (THC) is the principle psychoactive cannabinoid and the compound responsible for the analgesic, antiemetic and appetite-stimulating effects of cannabis [11,12]. Non-psychoactive cannabinoids such as cannabidiol (CBD), cannabichromene (CBC) and Δ9-tetrahydrocannabivarin (THCV), which possess diverse pharmacological activities, are also present in some varieties or strains [13-15]. Cannabinoids are synthesized as carboxylic acids and upon heating or smoking decarboxylate to their neutral forms; for example, Δ9-tetrahydrocannabinolic acid (THCA) is converted to THC. Although cannabinoid biosynthesis is not understood at the biochemical or genetic level, several key enzymes have been identified including a candidate polyketide synthase and the two oxidocyclases, THCA synthase (THCAS) and cannabidiolic acid (CBDA) synthase, which form the major cannabinoid acids [16-18]. Cannabinoid content and composition is highly variable among cannabis plants. Those with a high-THCA/low-CBDA chemotype are termed marijuana, whereas those with a low-THCA/high-CBDA chemotype are termed hemp. There are large differences in the minor cannabinoid constituents within these basic chemotypes. Breeding of cannabis for use as a drug and medicine, as well as improved cultivation practices, has led to increased potency in the past several decades with median levels of THC in dried female flowers of ca. 11% by dry weight; levels in some plants exceed 23% [10,19]. This breeding effort, largely a covert activity by marijuana growers, has produced hundreds of strains that differ in cannabinoid and terpenoid composition, as well as appearance and growth characteristics. Patients report medical marijuana strains differ in their therapeutic effects, although evidence for this is anecdotal. Cannabis has a diploid genome (2n = 20) with a karyotype composed of nine autosomes and a pair of sex chromosomes (X and Y). Female plants are homogametic (XX) and males heterogametic (XY) with sex determination controlled by an X-to-autosome balance system [20]. The estimated size of the haploid genome is 818 Mb for female plants and 843 Mb for male plants, owing to the larger size of the Y chromosome [21]. The genomic resources available for cannabis are mainly confined to transcriptome information: NCBI contains 12,907 ESTs and 23 unassembled RNA-Seq datasets of Illumina reads [22,23]. Neither a physical nor a genetic map of the cannabis genome is available. Here, we report a draft genome and transcriptome sequence of C. sativa Purple Kush (PK), a marijuana strain that is widely used for its medicinal effects [24]. We compared the genome of PK with that of the hemp cultivars 'Finola' and 'USO-31', and the transcriptome of PK flowers with that of 'Finola' flowers. We found evidence for the selection of cannabis for medicinal and drug (marijuana) use in the up-regulation of cannabinoid 'pathway genes' and the exclusive presence of functional THCA synthase (THCAS) in the genome and transcriptome of PK. RESULTS Sequencing the C. sativa PK genome and transcriptome We obtained DNA and RNA samples from plants of PK, a clonally propagated marijuana strain that may have been bred in California and is reportedly derived from an "indica" genetic background [24]. Genomic DNA was isolated from PK leaves and used to create six 2 ×100-bp Illumina paired-end libraries with median insert sizes of approximately 200, 300, 350, 580 and 660 bp. Sequencing each of these libraries produced > 92 gigabase (Gb) of data after filtering of low-quality reads (see below), which is equivalent to approximately 110× coverage of the estimated ~820 Mb genome. To improve repeat resolution and scaffolding, we supplemented these data with four 2 × 44-bp Illumina mate-pair libraries with a median insert size of approximately 1.8 kb and two 2 × 44-bp libraries with a median insert size of approximately 4.6 kb, adding 16.3 Gb of sequencing data in 185 million unique